News for Kythera Biopharmaceuticals Inc - Google Finance

Bearish MACD for Kythera Biopharmaceuticals Inc. - Tale of the Tape

Wed, 24 Apr 2013 16:20:11 GMT

Bearish MACD for Kythera Biopharmaceuticals Inc. - Tale of the Tape
NASDAQ - Apr 24, 2013

Kythera Biopharmaceuticals Inc. 's ( KYTH ) MACD indicator has moved into bearish territory with a reading of -0.1667. The Zacks Rank #4 ("Sell") stock decreased more than 2.85% to $22.47 in morning trade.

KYTHERA BIOPHARMACEUTICALS INC. : KYTHERA Biopharmaceuticals to ...

Tue, 07 May 2013 22:02:17 GMT

KYTHERA BIOPHARMACEUTICALS INC. : KYTHERA Biopharmaceuticals to ...
4-traders (press release) - May 7, 2013

LOS ANGELES, May 7, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the Bank of America Merrill Lynch 2013 Healthcare ...

KYTHERA Biopharmaceuticals Announces First Quarter 2013 Operating Results

Mon, 13 May 2013 20:12:51 GMT

KYTHERA Biopharmaceuticals Announces First Quarter 2013 Operating Results
GlobeNewswire (press release) - May 13, 2013

LOS ANGELES, May 13, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today reported financial results for its first quarter 2013, and provided an update on recent accomplishments.

Kythera Biopharmaceuticals (KYTH) Announces Quarterly Earnings, Beats ... - Zolmax

Kythera Biopharmaceuticals PT Lowered to $32.00 (KYTH)

Thu, 16 May 2013 18:40:02 GMT

Kythera Biopharmaceuticals PT Lowered to $32.00 (KYTH)
Daily Political - May 16, 2013

KYTHERA Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of prescription products for the aesthetic medicine market.

KYTHERA Biopharma To Present At Bank Of America Conference; Webcast At 2 ...

Tue, 14 May 2013 17:23:33 GMT

KYTHERA Biopharma To Present At Bank Of America Conference; Webcast At 2 ...
NASDAQ - May 14, 2013

(RTTNews.com) - KYTHERA Biopharmaceuticals, Inc. ( KYTH ) will present at the Bank of America Merrill Lynch 2013 Healthcare Conference in Las Vegas.

Esperion plans IPO to get drug to market

Sun, 05 May 2013 12:22:16 GMT

Esperion plans IPO to get drug to market
Crain's Detroit Business - May 5, 2013

based Merrimack Pharmaceuticals Inc. raised $100 million and Cambridge-based Verastem Inc., raised $55 million; New York-based Intercept Pharmaceuticals Inc. raised $75 million; and Calabasas, Calif.

Joe's Jeans, Virtual Piggy Among Week's Biggest Movers

Fri, 19 Apr 2013 21:46:51 GMT

Joe's Jeans, Virtual Piggy Among Week's Biggest Movers
Los Angeles Business Journal - Apr 19, 2013

Kythera Biopharmaceuticals Inc. gained 9.5 percent to $22.50. The Calabasas biotech reported promising clinical trial results for its experimental injectable treatment to reduce chin fat.

DIARY-NON S&P WEEK AHEAD

Fri, 10 May 2013 10:36:44 GMT

DIARY-NON S&P WEEK AHEAD
Reuters - May 10, 2013

... May AMC Q1 2013 INFORMATION SERVICES GROUP INC 0.01 3 0.03 13 May AMC Q1 2013 International Meal Company Holding 0.06 2 N/A 13 May AMC Q1 2013 InfuSystem Holdings Inc 0.01 1 N/A 13 May Q1 2013 Kythera Biopharmaceuticals -0.97 3 ...

Kythera Biopharmaceuticals Inc Announces Positive Magnetic Resonance Imaging (MRI) Results from Phase IIb Study of ATX-101 in Reduction of Submental Fat or 'Double Chin'

Sat, 13 Apr 2013 20:45:00 GMT

Kythera Biopharmaceuticals Inc Announces Positive Magnetic Resonance Imaging (MRI) Results from Phase IIb Study of ATX-101 in Reduction of Submental Fat or 'Double Chin'
Reuters Key Development - Apr 13, 2013

Kythera Biopharmaceuticals Inc Announces Positive Interim Results from Open-Label Study of ATX-101 in Reduction of Unwanted Submental Fat (SMF) or 'Double Chin'

Fri, 01 Mar 2013 14:10:00 GMT

Kythera Biopharmaceuticals Inc Announces Positive Interim Results from Open-Label Study of ATX-101 in Reduction of Unwanted Submental Fat (SMF) or 'Double Chin'
Reuters Key Development - Mar 1, 2013